Reducing HIV vaccine and prevention hesitancy among sexual and gender minority adolescents
减少性少数和性别少数青少年对艾滋病毒疫苗和预防的犹豫
基本信息
- 批准号:10620502
- 负责人:
- 金额:$ 65.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-16 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAccountingAddressAdolescentAdolescent and Young AdultAdultAffectAgeAreaAttitudeAwarenessBehaviorBehavioralBeliefBisexualBlack, Indigenous, People of ColorCOVID-19 pandemicCOVID-19 vaccineChicagoClinicClinicalCommunitiesDevelopmentEducationEffectivenessEnsureEpidemicExposure toFaceFeedbackFocus GroupsFosteringFriendsFutureGaysHIVHIV vaccineHIV/STDHealthHuman Papilloma Virus VaccineHybridsIndustryInfectionInjectableInterventionInterviewKnowledgeLearningMedia CampaignMedicalMethodsMisinformationModelingMotivationOralOutcomeParticipantPerceptionPersonsPredispositionPreventionPrevention approachPrevention strategyPrimary PreventionProductionProxyPublic HealthRandomized, Controlled TrialsResearchSafetySamplingSexual and Gender MinoritiesSexual and Gender Minority YouthSourceStreamSurveysTeenagersTestingTimeTrustUnited StatesVaccinesWorkYouthadolescent HIV preventionage groupbehavior changeboysburden of illnesscondomsdesigneffectiveness testingeffectiveness/implementation designgirlshealth communicationimplementation interventionimprovedinsightminority childrennovelpeerphase I trialpost interventionpre-exposure prophylaxispreferencepreventive interventionrandomized trialrecruitsocial mediasocial normsocial stigmasuccesstherapy developmenttransgendertruvadauptakevaccine acceptancevaccine distributionvaccine efficacyvaccine refusal
项目摘要
Project Summary
Adolescents and young adults are disproportionately affected by HIV in the USA, accounting for 21% of new
infections, with sexual and gender minority (SGM) youth carrying the greatest burden of disease. Recently,
phase I trials of potential HIV vaccines have opened possibilities for more prevention options available to youth
(in addition to oral and injectable PrEP). However, implementation of biomedical HIV prevention (e.g., PrEP)
among youth is hindered by numerous barriers that will likely affect HIV vaccine uptake, including
misinformation/lack of information, medical mistrust, and stigma. Youth-focused messaging on biomedical HIV
prevention is nearly nonexistent, leaving SGM teens with incomplete knowledge and fostering
misunderstanding and negative perceptions about biomedical HIV prevention methods. In addition, lessons
learned from the rollout of the HPV and COVID-19 vaccines indicate that unclear public health messaging, dis-
or misinformation from media/online sources, and vaccine stigma contributed to lack of trust, delayed uptake,
or outright refusal of vaccines. As HIV vaccines are in development, and PrEP remains underutilized among
SGM adolescents, now is the best time to understand and address biomedical HIV prevention concerns and
misinformation among youth. Therefore, this study proposes to preemptively debunk (i.e., “prebunk”)
misinformation about HIV vaccines, improve attitudes regarding multiple methods of biomedical HIV
prevention, and improve awareness, intentions, and uptake among SGM youth. In Aim 1, using an online
survey, we will gain comprehensive understanding of biomedical-HIV-prevention-related knowledge, social
norms and attitudes, and behavioral intent among a diverse nationwide sample of 700 SGM youth age 13-21.
In Aim 2, we will develop 8 brief youth-centered video vignettes aimed at prebunking vaccine misinformation
and presenting one or more complementary biomedical prevention methods (vaccine, PrEP, condoms). These
video messages will be delivered through narrative storytelling formats that are relevant, compelling, and
persuasive for youth. We will obtain feedback about the video vignettes from SGM youth and adult
stakeholders at multiple timepoints during video production and integrate this feedback into the final cuts. In
Aim 3, we will test the effectiveness of our messages in a randomized controlled trial with 500 SGM youth,
which will compare the video messages against an information-only control (e.g., publicly available information
from CDC on HIV vaccines and other forms of biomedical prevention). Three-month post-test outcomes
include vaccine acceptability and intentions, vaccine beliefs, and proxies for vaccine uptake (e.g., prevention
information seeking, HIV/STI testing, PrEP initiation.) Within this aim, we will also explore barriers and
facilitators to online- and in-person implementation via interviews with staff in community/clinical settings and
experts in entertainment education and streaming media.
项目摘要
在美国,青少年和年轻人受到艾滋病毒的影响不成比例,占新感染者的21%。
感染率最高的是性少数和性别少数青年,他们的疾病负担最重。最近,
潜在的艾滋病毒疫苗的第一阶段试验为青年人提供更多的预防选择开辟了可能性
(in除了口服和注射PrEP)。然而,实施生物医学艾滋病毒预防(例如,PrEP)
许多可能会影响艾滋病毒疫苗接种的障碍阻碍了青年人的免疫,
错误信息/缺乏信息,医疗不信任和耻辱。以青年为重点的关于生物医学艾滋病毒的宣传
预防几乎是不存在的,留下SGM青少年不完整的知识和培养
对生物医学艾滋病毒预防方法的误解和负面看法。此外,教训
从HPV和COVID-19疫苗的推出中了解到的情况表明,不明确的公共卫生信息,
或来自媒体/在线来源的错误信息,以及疫苗污名化导致缺乏信任,延迟接种,
或完全拒绝接种疫苗。由于艾滋病毒疫苗正在开发中,
SGM青少年,现在是了解和解决生物医学艾滋病毒预防问题的最佳时机,
年轻人中的错误信息。因此,本研究建议先发制人地揭穿(即,“prebunk”)
关于艾滋病毒疫苗的错误信息,改善对多种生物医学艾滋病毒方法的态度
预防,并提高认识,意图,并在SGM青年的吸收。在目标1中,使用在线
通过调查,我们将全面了解生物医学-艾滋病预防相关知识、社会
对全国700名13-21岁的SGM青少年进行了多元化样本的规范和态度以及行为意图。
在目标2中,我们将制作8个简短的以青年为中心的视频短片,旨在预防疫苗错误信息
并介绍一种或多种补充性生物医学预防方法(疫苗、PrEP、避孕套)。这些
视频信息将通过相关的、引人注目的、
对年轻人有说服力。我们将从SGM青少年和成人那里获得有关视频小插曲的反馈
在视频制作过程中的多个时间点与利益相关者进行沟通,并将此反馈整合到最终剪辑中。在
目标3,我们将在500名SGM青年的随机对照试验中测试我们的信息的有效性,
其将视频消息与仅信息控制(例如,公开信息
从疾病预防控制中心的艾滋病毒疫苗和其他形式的生物医学预防)。测试后3个月的结果
包括疫苗的可接受性和意图、疫苗信念和疫苗摄取的代理(例如,预防
信息寻求、艾滋病毒/性传播感染检测、PrEP启动。在这一目标下,我们还将探讨障碍,
通过与社区/临床环境中的工作人员进行访谈,促进在线和亲自实施,
娱乐教育和流媒体方面的专家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brandon J Hill其他文献
Brandon J Hill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 65.67万 - 项目类别: